Delivery Order SPE2DB22D2005-SPE2DB25FJLZ7
Award Date
5/6/25
Potential Completion Date
5/7/25
Potential Value
$14K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,028.36 firm-fixed-price delivery order is for the medication Trelegy Ellipta, a combination inhaled medication used to treat chronic obstructive pulmonary disease (COPD). The delivery order has a completion date of May 7, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,896.68 firm fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60s, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 9, 2024 and was awarded on December 6, 2024. This award is part of a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,907.62 firm fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of May 12, 2025 and does not have a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,406.85 Firm Fixed Price Delivery Order is for the supply of Trelegy Ellipta, a prescription medication used to treat chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of December 20, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,093.07 delivery order contract is for the provision of Trelegy Ellipta 100-62.5-25 60S, a pharmaceutical product, with a completion date of April 17, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,074.51 firm fixed-price delivery order is for the medication Trelegy Ellipta, a combination treatment for chronic obstructive pulmonary disease. The contract has an ultimate completion date of April 17, 2025 and is not a set-aside. AmerisourceBergen holds a substantial $999,999,999.00 Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,090.66 firm fixed-price delivery order is for the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a medication used for treating chronic obstructive pulmonary disease (COPD). The contract has an ultimate completion date of May 22, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,609.96 firm fixed-price delivery order is for the medication Trelegy Ellipta, a treatment used for chronic obstructive pulmonary disease (COPD). The award has an ultimate completion date of April 3, 2023 and was made on March 31, 2023. The contract does not have a set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,170.47 Firm Fixed Price Delivery Order covers the supply of TRELEGY ELLIPTA 100-62.5-25 60S, a pharmaceutical product, with a period of performance through January 29, 2025. The contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $1,460.94 firm-fixed-price delivery order is for the supply of Trelegy Ellipta 100-62.5-25 60S, a respiratory medication. The contract has an ultimate completion date of August 9, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to...